Mangaonkar, A., Fernandez, J., Burgess, A., McCullough, K., Finke, C., Lasho, T., Amundson, M., Saliba, A., Matin, A., Al-Kali, A., Alkhateeb, H., Shah, M., Knopf, B., Witzig, T., Patnaik, M. (2025). LS1781 (Arm E): Phase II clinical trial to assess the safety and efficacy of high dose IV ascorbic acid with decitabine in newly diagnosed TET2 mutant chronic myelomonocytic leukemia (CMML). Blood. https://doi.org/10.1182/blood-2025-2079